Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1188/21.CJON.28-32 http://scihub22266oqcxt.onion/10.1188/21.CJON.28-32 33480877!ä!33480877 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+J+Oncol+Nurs 2021 ; 25 (1): 28-32 Nephropedia Template TP {{tp|p=33480877|t=2021. Convalescent Plasma: Education and Administration Implications |pdf=|usr=}}{{33480877}} gab.com Text Convalescent Plasma: Education and Administration Implications JO: Clin J Oncol Nurs http://www.kidney.de/pget.php?&tw=1&pmid=33480877 #FOAvip Convalescent plasma has emerged as a treatment that merits consideration for COVID-19-positive patients requiring hospitalization. With millions of cases of COVID-19 being reported worldwide, nurses across specialties are caring for infected patients and are often the primary patient educators about convalescent plasma treatment. Keeping abreast of current clinical guidelines and evidence-based practice allows nurses to identify patients who should be considered for treatment, understand the administration guidelines, and be aware of the toxicity profile to provide safe and high-quality care to patients. The purpose of this article is to provide information on convalescent plasma as a treatment for COVID-19. Twit Text FOAVip Convalescent Plasma: Education and Administration Implications ????Clin J Oncol Nurs http://www.kidney.de/pget.php?&tw=1&pmid=33480877 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33480877 #FOAvip English Wikipedia <ref>{{Cite pmid|33480877}}</ref> Convalescent Plasma: Education and Administration Implications #MMPMID33480877 Martin JC Clin J Oncol Nurs 2021[Feb]; 25 (1): 28-32 PMID33480877show ga Convalescent plasma has emerged as a treatment that merits consideration for COVID-19-positive patients requiring hospitalization. With millions of cases of COVID-19 being reported worldwide, nurses across specialties are caring for infected patients and are often the primary patient educators about convalescent plasma treatment. Keeping abreast of current clinical guidelines and evidence-based practice allows nurses to identify patients who should be considered for treatment, understand the administration guidelines, and be aware of the toxicity profile to provide safe and high-quality care to patients. The purpose of this article is to provide information on convalescent plasma as a treatment for COVID-19. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antibodies, Viral/*administration & dosage/*therapeutic use[MESH] |COVID-19/*immunology/*therapy[MESH] |Female[MESH] |Health Personnel/*education[MESH] |Humans[MESH] |Immunization, Passive/methods/*standards[MESH] |Male[MESH] |Middle Aged[MESH] |Plasma/*immunology[MESH] |Practice Guidelines as Topic[MESH] |SARS-CoV-2[MESH]Convalescent Plasma: Education and Administration Implications (epmc).pdf DeepDyve Pubget Overpricing